Volex reports 28% organic revenue growth and medical expansion
Volex posted a 28% year-on-year organic revenue increase for the first four months, driven by strong demand in data centers and electric vehicle products. Operating expenses were well-managed, lifting profit margins. The company also expanded its medical product range by acquiring full ownership of Kepler SignalTek and moved to the London Stock Exchange Main Market.